Targeting the microcirculation may provide important new therapeutic perspectives for the management of hypertension, addressing imperfect blood pressure control and end-organ damage.
T he number of effective agents available for the treatment of hypertension is now substantial. However, in spite of this, most would agree that there is still considerable scope for improvement in the way hypertension is managed. In many countries, the great majority of hypertensive subjects still show imperfect blood pressure control. 1 Furthermore, the reductions or improvements in end-organ damage seen during antihypertensive therapy do not always correlate well with the reduction in arterial blood pressure achieved. Thus, there seems to be a need for new therapeutic perspectives in the treatment of hypertension. One important new perspective might be provided by an enhanced appreciation of the importance of the microcirculation in the pathophysiology and treatment of hypertension.
Lévy et al. (Tue,) conducted a review in Hypertension. Targeting the microcirculation may provide important new therapeutic perspectives for the management of hypertension, addressing imperfect blood pressure control and end-organ damage.